PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $40,000 | +122.2% | 1,749 | -2.5% | 0.00% | – |
Q3 2020 | $18,000 | -47.1% | 1,793 | -21.4% | 0.00% | – |
Q2 2020 | $34,000 | +30.8% | 2,280 | +6.2% | 0.00% | – |
Q1 2020 | $26,000 | +13.0% | 2,146 | +50.1% | 0.00% | – |
Q4 2019 | $23,000 | +53.3% | 1,430 | +19.0% | 0.00% | – |
Q3 2019 | $15,000 | – | 1,202 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 13,822,463 | $318,884,000 | 2.79% |
HARVEST MANAGEMENT LLC | 70,000 | $1,615,000 | 1.32% |
HARVEST MANAGEMENT LLC | 70,000 | $1,615,000 | 1.32% |
EQUITEC PROPRIETARY MARKETS, LLC | 215,300 | $4,967,000 | 1.30% |
BARDIN HILL MANAGEMENT PARTNERS LP | 206,867 | $4,773,000 | 1.00% |
Boxer Capital, LLC | 1,123,105 | $25,910,000 | 0.83% |
TIG Advisors, LLC | 709,282 | $16,363,000 | 0.82% |
Newtyn Management, LLC | 153,617 | $3,544,000 | 0.82% |
ALPINE ASSOCIATES MANAGEMENT INC. | 857,705 | $19,787,000 | 0.81% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 205,800 | $4,748,000 | 0.74% |